The following is an excerpt.
The Supreme Court heard the first day of oral arguments Monday in a case that could upend the biotech industry and DNA patent law, and have broad impact on biotech research. The legal echoes also could extend far beyond genetics.
Said baldy, the case revolves around what appears to be a deliberate attempt by one farmer to circumvent the law. Bowman v Monsanto is the long-anticipated square off between a 75-year old Indiana farmer and the world’s largest agricultural biotechnology firm. The decision will turn on the minutiae of patent law, but the implications will extend to all cutting-edge technologies.